Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer.
| Autor: | Lehrer, Steven, Rheinstein, Peter H. |
|---|---|
| Zdroj: | American Journal of Clinical Oncology; Dec2024, Vol. 47 Issue 12, p591-594, 4p |
| Databáze: | Complementary Index |
| Externí odkaz: |
|